Regulatory and Economic Aspects in Oncology(Recent Results in Cancer Research)

肿瘤学中的监管与经济方面

肿瘤学

原   价:
1327.5
售   价:
1062.00
优惠
平台大促 低至8折优惠
发货周期:通常付款后3-5周到货!
出  版 社
出版时间
2019年01月23日
装      帧
精装
ISBN
9783030012069
复制
页      码
205
语      种
英文
综合评分
暂无评分
我 要 买
- +
库存 30 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
This book explores topics of importance to all who have an interest in economic methods for assessment of the efficacy and effectiveness of new cancer treatments and in regulatory measures relating to their marketing authorization and pricing. Targeted therapies and modern immunotherapy are placing a substantial strain on health care budgets. Regulation and economic methods to assess the parameters for establishing efficacy and effectiveness are therefore of prime importance. Payer authorities have to determine whether the use of these novel therapies yields clinical benefits that justify their increasing cost. In the simplest terms, cost-effectiveness analyses quantify the ratio between the extent to which an intervention raises healthcare costs and the extent to which it improves health outcomes. Rigorous cost-effectiveness analyses translate all health outcomes into quality-adjusted life years. On the other hand, in order to sustain innovation, price regulations must be coupled with efforts to ensure that drug companies are still able to recoup their investments in high-risk and high-costs research programs. Ultimately, decisions regarding health care expenditures are also a question of society’s willingness to pay.
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个